Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis

Clinical relapses are common in anti-neutrophil cytoplasm antibody (ANCA)–associated vasculitis, necessitating repeated treatment with immunosuppressive therapy, and increasing the risks of severe adverse events. Better understanding the basis of relapse would help stratify patients, testing the not...

Descripción completa

Detalles Bibliográficos
Autor principal: Salama, Alan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943777/
https://www.ncbi.nlm.nih.gov/pubmed/31922056
http://dx.doi.org/10.1016/j.ekir.2019.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943777/
https://www.ncbi.nlm.nih.gov/pubmed/31922056
http://dx.doi.org/10.1016/j.ekir.2019.10.005

Ejemplares similares